MISSION

At RIVANNA, our shared vision and responsibility are to elevate global standards of care through the commercialization of world-first imaging-based medical technologies.

ABOUT RIVANNA

We are a privately held designer, manufacturer, and distributor of medical technologies and services. Our automated clinician-assistance solutions improve decision-making, clinician workflows, health outcomes, and patient satisfaction.

Slide Slide Slide

RIVANNA MILESTONES

DISTRIBUTION ALLIANCE WITH TRI-ANIM

LAUNCH OF TRUE-VIEW PRODUCT LINE

PURCHASED 10,000 SQ FT FACILITY TO FACILITATE MANUFACTURING, COMMERCIAL, AND R&D GROWTH

ACCURO SECOND-GENERATION LAUNCH WITH THORACIC PARAMEDIAN EPIDURAL GUIDANCE PRESET

AWARDED VIRGINIA CATALYST GRANT TO DEVELOP LUMBAR PUNCTURE GUIDANCE SYSTEM ($800,000)

AWARDED PHASE II NIH SBIR TO DEVELOP BONE MARROW BIOPSY GUIDANCE SYSTEM ($1,500,000)

DISTRIBUTION ALLIANCE WITH B.BRAUN JAPAN

CHINESE CFDA REGISTRATION

ACCURO FDA 510(K) PEDIATRIC IMAGING CLEARANCE

AWARDED PHASE II NIH NIGMS SBIR TO DEVELOP THORACIC EPIDURAL GUIDANCE MODE FOR ACCURO ($1,498,048)

ACCURO CE MARK

AWARDED PHASE II NIH NIBIB SBIR TO ADVANCE ULTRASOUND-BASED FRACTURE DETECTION TECHNOLOGY ($1,484,330)

SERIES B FUNDING

ACCURO FDA 510(K) CLEARANCE AND PRODUCT LAUNCH

AWARDED PHASE II NIH NIBIB SBIR TO PRODUCTIZE ACCURO ($1,353,021)

AWARDED PHASE I NIH NIAMS SBIRTO DEVELOP ULTRASOUND-BASED FRACTURE DETECTION TECHNOLOGY ($210,418)

AWARDED PHASE II NSF SBIR TO PRODUCTIZE ACCURO ($1,410,000) 

AWARDED PHASE I NIH NIBIB SBIR TO DEVELOP ULTRASOUND-BASED BONE IMAGING TECHNOLOGY ($231,868)

AWARDED PHASE I NSF SBIR TO DEVELOP AUTOMATIC SPINE RECOGNITION TECHNOLOGY ($149,903)

SERIES A FUNDING

RIVANNA IS FOUNDED

RIVANNA HISTORY

RIVANNA was founded in 2010 by graduate students at the University of Virginia. Co-founder Will Mauldin initiated the founding of RIVANNA after taking a course at the Darden School of Business as a Ph.D. student in Biomedical Engineering (BME). Will saw an opportunity to apply his expertise in medical ultrasound technologies to address the high failure rates associated with epidural and spinal anesthesia placement. Fortunately, one of Will’s fellow BME graduate students had industrial product development experience, and so Kevin Owen was recruited to round out the team and formally establish the company.

With no company facilities or funding, early-stage development was performed in Kevin’s home attic, including assembling the first circuit boards in a toaster oven. Will created the first prototype ultrasound transducers using a trailer hitch and hot glue, which was tested in a deer spine phantom with materials obtained from a recent hunting trip. This initial prototype provided the basic concept and preliminary data to attract RIVANNA’s first outside funding from the National Institutes of Health.

With a toaster oven, a trailer hitch, and deer-spine phantom, the initial Accuro prototype was a functional ultrasound scanning system due to resourcefulness and shared vision and responsibility.

Based in Charlottesville, VA, RIVANNA operates an FDA-registered and ISO 13485:2016 certified manufacturing facility where it produces the Accuro® product line and related medical equipment and components.